首页> 外文期刊>Journal of International Medical Research >Randomized Study of the Efficacy and Safety of Oral Elderberry Extract in the Treatment of Influenza A and B Virus Infections
【24h】

Randomized Study of the Efficacy and Safety of Oral Elderberry Extract in the Treatment of Influenza A and B Virus Infections

机译:口服接骨木浆果提取物治疗甲型和乙型流感病毒感染的功效和安全性的随机研究

获取原文
           

摘要

Elderberry has been used in folk medicine for centuries to treat influenza, colds and sinusitis, and has been reported to have antiviral activity against influenza and herpes simplex. We investigated the efficacy and safety of oral elderberry syrup for treating influenza A and B infections. Sixty patients (aged 18-54 years) suffering from influenza-like symptoms for 48 h or less were enrolled in this randomized, double-blind, placebo-controlled study during the influenza season of 1999-2000 in Norway. Patients received 15 ml of elderberry or placebo syrup four times a day for 5 days, and recorded their symptoms using a visual analogue scale. Symptoms were relieved on average 4 days earlier and use of rescue medication was significantly less in those receiving elderberry extract compared with placebo. Elderberry extract seems to offer an efficient, safe and cost-effective treatment for influenza. These findings need to be confirmed in a larger study.
机译:接骨木浆果已经在民间医学中使用了多个世纪,用于治疗流感,感冒和鼻窦炎,据报道,它对流感和单纯疱疹具有抗病毒活性。我们研究了口服接骨木浆果糖浆治疗甲型和乙型流感感染的功效和安全性。在挪威1999-2000年流感季节期间,有60名患者(年龄在18-54岁之间)出现了类流感症状48小时或更短时间,参加了这项随机,双盲,安慰剂对照研究。患者每天四次接受15毫升接骨木浆果或安慰剂糖浆,持续5天,并使用视觉模拟量表记录其症状。与安慰剂相比,接受接骨木浆果提取物的患者平均在治疗前4天症状得到缓解,救援药物的使用显着减少。接骨木浆果提取物似乎为流感提供了一种有效,安全且具有成本效益的治疗方法。这些发现需要在更大的研究中得到证实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号